TD Waterhouse Canada’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.47M | Buy |
4,613
+4,586
| +16,985% | +$2.45M | 0.02% | 397 |
|
|
2025
Q1 | $16.6K | Sell |
27
-26
| -49% | -$16K | ﹤0.01% | 1299 |
|
|
2024
Q4 | $37.8K | Sell |
53
-4,240
| -99% | -$3.02M | ﹤0.01% | 1147 |
|
|
2024
Q3 | $4.49M | Sell |
4,293
-413
| -9% | -$432K | 0.04% | 275 |
|
|
2024
Q2 | $4.97M | Sell |
4,706
-103
| -2% | -$109K | 0.04% | 242 |
|
|
2024
Q1 | $4.69M | Buy |
4,809
+881
| +22% | +$860K | 0.04% | 259 |
|
|
2023
Q4 | $3.7M | Sell |
3,928
-670
| -15% | -$630K | 0.03% | 249 |
|
|
2023
Q3 | $4.62M | Buy |
4,598
+2,709
| +143% | +$2.72M | 0.05% | 204 |
|
|
2023
Q2 | $1.38M | Buy |
1,889
+75
| +4% | +$54.8K | 0.01% | 373 |
|
|
2023
Q1 | $1.52M | Sell |
1,814
-81
| -4% | -$68K | 0.02% | 353 |
|
|
2022
Q4 | $1.39M | Sell |
1,895
-363
| -16% | -$267K | 0.02% | 357 |
|
|
2022
Q3 | $1.74M | Buy |
2,258
+544
| +32% | +$419K | 0.02% | 323 |
|
|
2022
Q2 | $1.02M | Buy |
1,714
+57
| +3% | +$34K | 0.01% | 408 |
|
|
2022
Q1 | $1.15M | Buy |
1,657
+104
| +7% | +$72.3K | 0.01% | 424 |
|
|
2021
Q4 | $961K | Buy |
+1,553
| New | +$961K | 0.01% | 492 |
|